Does PAZOPANIB Cause Thrombotic microangiopathy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Thrombotic microangiopathy have been filed in association with PAZOPANIB (Pazopanib). This represents 0.1% of all adverse event reports for PAZOPANIB.
10
Reports of Thrombotic microangiopathy with PAZOPANIB
0.1%
of all PAZOPANIB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From PAZOPANIB?
Of the 10 reports, 2 (20.0%) resulted in death, 7 (70.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for PAZOPANIB.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which PAZOPANIB Alternatives Have Lower Thrombotic microangiopathy Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS